CDK9-IN-27
Product Specifications
Target
CDK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CDK9-IN-27 (Compound 6a), a CDK9 inhibitor with an IC50 of 0.424 μM, induces apoptosis and S-phase cell cycle arrest. It exhibits cytotoxicity against HepG2, HCT-116, and MCF-7 cell lines, with IC50 values ranging from 10.31 to 40.34 μM, rendering it applicable in cancer research [1].
Molecular Formula
C23H18ClN5O3
Molecular Weight
447.87
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
WYB18652-01 25 mg
6-[ (3-Methoxyphenyl) methyl]-4-methyl-2-methylsulfinylthieno[3,4]pyrrolo[1,3-d]pyridazin-5-one
Sign In for Pricing
View Details ![6-[ (3-Methoxyphenyl) methyl]-4-methyl-2-methylsulfinylthieno[3,4]pyrrolo[1,3-d]pyridazin-5-one](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
WYB18652-02 50 mg
6-[ (3-Methoxyphenyl) methyl]-4-methyl-2-methylsulfinylthieno[3,4]pyrrolo[1,3-d]pyridazin-5-one
Sign In for Pricing
View Details ![6-[ (3-Methoxyphenyl) methyl]-4-methyl-2-methylsulfinylthieno[3,4]pyrrolo[1,3-d]pyridazin-5-one](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
WYB18652-03 100 mg
6-[ (3-Methoxyphenyl) methyl]-4-methyl-2-methylsulfinylthieno[3,4]pyrrolo[1,3-d]pyridazin-5-one
Sign In for Pricing
View Details LV809617 1.0 µg DNA
C14orf128 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details